Seeing Is Believing
PHAT is currently covered by 5 analysts with an average price target of $23. This is a potential upside of $11.95 (108.14%) from yesterday's end of day stock price of $11.05.
Phathom Pharmaceuticals's activity chart (see below) currently has 12 price targets and 32 ratings on display. The stock rating distribution of PHAT is 17.39% HOLD and 82.61% BUY.
Analysts average stock forecasts to be materialized ratio is 22.92% with an average time for these price targets to be met of 40.25 days.
Highest price target for PHAT is $26, Lowest price target is $10, average price target is $23.
Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 07-Mar-2024.
Currently out of the existing stock ratings of PHAT, 4 are a HOLD (17.39%), 19 are a BUY (82.61%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
26
$14.95 (135.29%)
26
22 days ago
0/13 (0%)
$16.91 (186.03%)
Hold
10
$-1.05 (-9.50%)
4 months 26 days ago
5/6 (83.33%)
$1.27 (14.55%)
34
Buy
15
$3.95 (35.75%)
22
1 years 28 days ago
1/6 (16.67%)
$5.99 (66.48%)
152
Buy
30
$18.95 (171.49%)
35
1 years 28 days ago
0/4 (0%)
$20.99 (232.96%)
Buy
62
$52.74 (569.55%)
50
2 years 5 months 11 days ago
0/2 (0%)
$22.82 (77.64%)
What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?
Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?